Flupirtin ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
13多発性硬化症/視神経脊髄炎2

13. 多発性硬化症/視神経脊髄炎


臨床試験数 : 3,340 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00623415
(ClinicalTrials.gov)
December 200715/2/2008Flupirtine as Oral Treatment in Multiple SclerosisMulticentric, Prospective, Double Blind, Randomized/Stratified, Placebo-controlled Pilot-study for Evaluation of Safety and Efficacy of Flupirtine add-on to Interferon-ß1b on Neurodegeneration in Patients With Relapsing Remitting Multiple SclerosisRelapsing Remitting Multiple SclerosisDrug: Flupirtine;Drug: PlaceboCharite University, Berlin, GermanyBayerTerminated18 Years60 YearsAll30Phase 2Germany
2EUCTR2006-005262-39-DE
(EUCTR)
30/05/200709/03/2007Flupirtin as Oral Treatment in MS - FLORIMSFlupirtin as Oral Treatment in MS - FLORIMS Relapsing-remitting multiple sclerosisTrade Name: Trancopal Dolo
Product Name: Flupirtin
INN or Proposed INN: Flupirtin
Other descriptive name: Flupirtinmaleat
Charité-Universitätsmedizin BerlinNULLNot RecruitingFemale: yes
Male: yes
80Phase 2Germany